133
Views
0
CrossRef citations to date
0
Altmetric
News & Views

Institutional Profile: The Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre at the Montreal Heart Institute

&
Pages 131-136 | Published online: 17 Jan 2013

References

  • Barter PJ , CaulfieldM, ErikssonM et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357(21) , 2109–2122 (2007).
  • Nicholls SJ , TuzcuEM, BrennanDM, TardifJC, NissenSE. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation). Circulation118(24) , 2506–2514 (2008).
  • Bruckert E , HayemG, DejagerS, YauC, BegaudB. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients – the PRIMO study. Cardiovasc. Drugs Ther.19(6) , 403–414 (2005).
  • Larosa JC , GrundySM, WatersDD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Engl. J. Med. 352(14) , 1425–1435 (2005).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.